We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Q&A Guidance on Biosimilars and Interchangeable Biosimilars
FDA Issues Final Q&A Guidance on Biosimilars and Interchangeable Biosimilars
The FDA has finalized its Q&A guidance on biosimilars and interchangeable biosimilars, addressing hot topics for developers, including submitting supplements for approved biosimilar applications and for manufacturing changes.